data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Simulations Plus
(NASDAQ:SLP)
48.75
2.27[4.88%]
At close: May 27
48.75
00
After Hours: 4:01PM EDT
Day High/Low46.89 - 48.82
52 Week High/Low35.18 - 57.96
Open / Close46.99 / 48.75
Float / Outstanding13.5M / 20.2M
Vol / Avg.117.9K / 109.6K
Mkt Cap985.1M
P/E87.05
50d Avg. Price47.01
Div / Yield0.24/0.49%
Payout Ratio42.86
EPS0.22
Total Float13.5M

Simulations Plus (NASDAQ:SLP), Quotes and News Summary

Simulations Plus (NASDAQ: SLP)

Day High/Low46.89 - 48.82
52 Week High/Low35.18 - 57.96
Open / Close46.99 / 48.75
Float / Outstanding13.5M / 20.2M
Vol / Avg.117.9K / 109.6K
Mkt Cap985.1M
P/E87.05
50d Avg. Price47.01
Div / Yield0.24/0.49%
Payout Ratio42.86
EPS0.22
Total Float13.5M
Benzinga - May 5, 2022, 8:34AM
Benzinga - Apr 21, 2022, 8:34AM
Benzinga - Apr 6, 2022, 4:07PM
Benzinga - Mar 29, 2022, 8:31AM
Benzinga - Jan 20, 2022, 8:36AM
Benzinga - Jan 13, 2022, 8:32AM
Benzinga - Jan 6, 2022, 4:14PM
Benzinga - Dec 2, 2021, 8:32AM
Benzinga - Oct 26, 2021, 12:16PM
Benzinga - Oct 26, 2021, 9:08AM
Benzinga - Oct 26, 2021, 8:33AM
Benzinga - Oct 25, 2021, 2:19PM
Benzinga - Oct 25, 2021, 2:16PM
Benzinga - Sep 23, 2021, 8:42AM
Benzinga - Aug 19, 2021, 8:43AM
Benzinga - Aug 4, 2021, 9:20AM
load more
Sector: Health Care.Industry: Health Care Technology
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-11
REV
Q2 2022Est.ActualSurprise
EPS0.1400.210 0.0700
REV13.940M14.796M856.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Simulations Plus Questions & Answers

Q
How do I buy Simulations Plus (SLP) stock?
A

You can purchase shares of Simulations Plus (NASDAQ: SLP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Simulations Plus's (SLP) competitors?
Q
What is the target price for Simulations Plus (SLP) stock?
A

The latest price target for Simulations Plus (NASDAQ: SLP) was reported by Craig-Hallum on Tuesday, October 26, 2021. The analyst firm set a price target for 53.00 expecting SLP to rise to within 12 months (a possible 8.72% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Simulations Plus (SLP)?
A

The stock price for Simulations Plus (NASDAQ: SLP) is $48.75 last updated May 27, 2022, 8:00 PM UTC.

Q
Does Simulations Plus (SLP) pay a dividend?
A

A quarterly cash dividend of $0.06 per share of Class A Common Stock. The quarterly cash dividend was payable on May 2, 2022 to stockholders of record on April 22, 2022.

Q
When is Simulations Plus (NASDAQ:SLP) reporting earnings?
A

Simulations Plus’s Q3 earnings are confirmed for Monday, July 11, 2022.

Q
Is Simulations Plus (SLP) going to split?
A

There is no upcoming split for Simulations Plus.

Q
What sector and industry does Simulations Plus (SLP) operate in?
A

Simulations Plus is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.